# Topical Crisaborole in Patients with Alopecia Areata

> **NCT04299503** · PHASE2 · WITHDRAWN · sponsor: **Tufts Medical Center**

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** Crisaborole Topical Ointment
- **DRUG:** Placebo Topical Ointment

## Key facts

- **NCT ID:** NCT04299503
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-03-06
- **Primary completion:** 2022-03
- **Final completion:** 2022-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to identify subjects to meet inclusion criteria
- **Last updated:** 2024-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04299503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04299503, "Topical Crisaborole in Patients with Alopecia Areata". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04299503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*